ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

NCI Advisory Group, Other Cancer Meetings

August 26, 1977

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI

September 13, 1996

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

Payline For 1988 Would Be Around 160 With President’s Budget

January 16, 1987